Kyowa inks buyout deal for ProStrakan
Japanese drugmaker, Kyowa Hakko Kirin, has further expanded its presence in foreign markets after agreeing a deal to buy Scottish drug firm, ProStrakan.
Japanese drugmaker, Kyowa Hakko Kirin, has further expanded its presence in foreign markets after agreeing a deal to buy Scottish drug firm, ProStrakan.
Clinical trial management company, BioClinica, has joined with advisory and consulting firm, Paragon Solutions, to conduct a study which will assess business challenges and trends facing clinical trial chain management.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Hemispherx Biopharma, Novartis and InVivo.
A study by research fir, Cutting Edge Information (CEI) claims Asia offers clinical development teams 'unique benefits' for running trials.
Consolidation of CMOs will support use of completely outsourced production and distribution networks in the near future.
Bayer has announced plans to considerably expand its pharmaceutical activities in the coming years.
Sigma-Aldrich is repackaging certain BASF pharmaceutical excipients to make them available for the academic research and development sector.